Delphia Therapeutics
Cambridge
About Delphia Therapeutics
Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells. It studies cancer-driving pathways and their effect on creating cancer medicines. Delphia Therapeutics is based in Boston, USA.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $67.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2024)
- Website: delphiatx.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/delphia-therapeutics-105590 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.